If you've been paying attention to the weight loss space over the last few years, you've heard the names. Semaglutide. Tirzepatide. GLP-1. The headlines have been hard to miss — and for good reason. These medications represent a genuine shift in what's possible for men who've struggled to lose weight despite doing everything right.

But the conversation often stops at "which one is better?" That's the wrong question. The right question is: which one is right for you, right now, given where your body is and what you're trying to accomplish?

That's the conversation we have with every patient at Gables.

What Semaglutide Does

Semaglutide is a GLP-1 receptor agonist — a medication that mimics glucagon-like peptide-1, a hormone your gut naturally releases after eating. GLP-1 signals your brain that you're full, slows gastric emptying (so food moves through your stomach more slowly), and reduces appetite at the neurological level.

The result is that you eat less — not because you're white-knuckling a diet, but because your hunger signals are genuinely quieter. For men who've spent years fighting cravings and portion sizes, this is a meaningful change.

Beyond appetite suppression, semaglutide improves insulin sensitivity and supports better blood sugar regulation. For men with insulin resistance — which is extremely common in those carrying excess abdominal fat — this metabolic benefit compounds the weight loss effect.

Clinical trials showed semaglutide producing average weight loss of around 15% of body weight over 68 weeks. For a 220-pound man, that's roughly 33 pounds. That's not a small number — and it's achieved with a once-weekly injection at a dose that's titrated up gradually to minimize side effects.

Semaglutide is well-tolerated by most men. The most common side effects — nausea, mild GI discomfort — tend to be dose-dependent and typically resolve as the body adjusts. The slow titration schedule is specifically designed to minimize these effects.

What Tirzepatide Does Differently

Tirzepatide does everything semaglutide does — and then some.

Where semaglutide targets only the GLP-1 receptor, tirzepatide is a dual agonist: it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. GIP is another gut hormone involved in insulin secretion, fat metabolism, and energy balance. Activating both pathways together produces a synergistic effect that goes beyond what either hormone achieves alone.

The clinical data reflects this. In the SURMOUNT-1 trial, tirzepatide at its highest dose (15 mg) produced average weight loss of 22.5% of body weight — significantly more than semaglutide in comparable trials. For that same 220-pound man, that's nearly 50 pounds.

Tirzepatide also tends to work faster. Men on tirzepatide often notice meaningful appetite suppression and early weight loss within the first few weeks of treatment, even at lower doses. The dose-response relationship is also more pronounced — as the dose increases from 2.5 mg through 5, 7.5, 10, 12.5, and up to 15 mg, the weight loss effect continues to build.

Beyond weight loss, tirzepatide has shown impressive effects on metabolic markers — triglycerides, blood pressure, fasting glucose, and HbA1c — that matter for long-term cardiovascular and metabolic health.

So Why Wouldn't Everyone Just Choose Tirzepatide?

This is where the nuance matters — and where the "stronger is always better" logic breaks down.

Tolerability varies. Tirzepatide's dual mechanism is more potent, but that potency cuts both ways. Some men experience more pronounced GI side effects — nausea, bloating, changes in bowel habits — particularly during the early titration phase. For most, these resolve with time and careful dose management. But for some, the side effect profile makes a slower, gentler approach with semaglutide the smarter starting point.

Your baseline matters. A man who needs to lose 15–20 pounds and is otherwise metabolically healthy may respond beautifully to semaglutide without ever needing the additional horsepower of tirzepatide. A man with significant insulin resistance, a larger amount of weight to lose, or a history of poor response to other interventions may benefit from tirzepatide's dual mechanism from the start.

Cardiovascular and metabolic history. Both medications have favorable cardiovascular profiles, but your individual history — blood pressure, lipid panel, glucose regulation — informs which is the more appropriate choice and at what starting dose.

What you're combining it with. At Gables, most of our patients are on TRT and often additional peptides like sermorelin or NAD+. The interaction between GLP-1 therapy and testosterone optimization is genuinely synergistic — TRT helps preserve lean muscle mass during weight loss, which is one of the primary concerns with any aggressive fat loss protocol. Understanding how these pieces fit together is part of how we build protocols that produce results without compromising muscle.

Cost and access. Tirzepatide is newer and, in some cases, more expensive or harder to access depending on supply. For some patients, starting with semaglutide and transitioning to tirzepatide if needed is the most practical path.

The Honest Answer: There Isn't One Right Choice

Tirzepatide is, by the clinical data, the more powerful medication. If you're asking which one produces more weight loss on average, the answer is tirzepatide — and it's not particularly close.

But "more powerful" doesn't mean "better for you." Medicine doesn't work that way, and any clinic that tells you otherwise is selling you a protocol, not a solution.

The best GLP-1 medication for you is the one that:

• Your body tolerates well enough to stay on consistently
• Fits your metabolic baseline and weight loss goals
• Works synergistically with the rest of your protocol
• Can be titrated appropriately based on how you're actually responding

That last point is critical. Both semaglutide and tirzepatide are dose-dependent medications. Getting the titration right — moving up slowly enough to minimize side effects, but assertively enough to reach a therapeutic dose — is one of the most important variables in your outcome. It's not something that should be set and forgotten.

How We Approach This at Gables

When you come to Gables for a weight loss consultation, we don't start with a medication. We start with your labs.

A comprehensive metabolic panel, fasting insulin, HbA1c, a full hormone panel, and a detailed intake conversation give us the picture we need to make a recommendation that's actually based on your biology — not a one-size-fits-all protocol.

From there, we'll discuss whether semaglutide or tirzepatide is the right starting point, what dose makes sense given your baseline, and how it fits into the broader context of your hormone optimization. If you're not already on TRT, we'll evaluate whether that's appropriate — because the combination of testosterone optimization and GLP-1 therapy is, for many men, significantly more effective than either alone.

Once you're on a protocol, we monitor. We check in on how you're feeling, track your labs at regular intervals, and adjust your dose based on your response. If you're tolerating your current dose well and your progress has plateaued, we move up. If you're experiencing side effects that are affecting your quality of life, we back off and find the right level for your body.

The goal isn't to put you on the highest dose possible. The goal is to find the dose that produces the best results with the best quality of life — and to keep adjusting until we get there.

Weight loss is not a set-it-and-forget-it process. It's a clinical one. And at Gables, that's exactly how we treat it.